Expert Review of Pharmacoeconomics & Outcomes Research

Article	Citations
Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy	147
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications	43
An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health	40
Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic	35
Organizational measures aiming to combat COVID-19 in the Russian Federation: the first experience	32
Distinguishing features in the assessment of mHealth apps	30
Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review	28
Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses	28
Tools to assess the quality of life in patients with Parkinson’s disease: a systematic review	27
First-line atezolizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer: a cost-effectiveness analysis from China	25
Health-related quality of life in patients with chronic kidney disease	22
Will the Markov model and partitioned survival model lead to different results? A review of recent economic evidence of cancer treatments	20
Evaluation instruments for executive functions in children and adolescents: a systematic review	18
Valuing health outcomes: developing better defaults based on health opportunity costs	14
The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries	14
Cost-effectiveness of adding durvalumab to first-line chemotherapy for extensive-stage small-cell lung cancer in China	14
Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia	14
Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review	13
Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing	13
Challenges in demonstrating the value of disease-modifying therapies for Alzheimer’s disease	13
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease	13
Burden of communicable diseases and cost of illness: Asia pacific region	12
Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study	12
Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore	12
Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region	12

A comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai population	12
Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis	11
Economic evaluation of a multimodal intervention in pre-frail and frail older people with diabetes mellitus: the MID-FRAIL project	11
The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review	11
Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia	10
The pharmacoeconomic impact of follitropin alpha biosimilars in IVF therapy in Europe: a report of the literature	10
Estimating the economic consequences of substance use and substance use disorders	10
The efficacy and economic evaluation of roxadustat treatment for anemia in patients with kidney disease not receiving dialysis	9
Artificial intelligence in outcomes research: a systematic scoping review	9
Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder	9
Can we achieve affordable cancer medicine prices? Developing a pathway for change	9
How do biosimilars sustain value, affordability, and access to oncology care?	9
Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review	8
Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer in Australia	8
Economic burden associated with stroke in India: insights from national sample survey 2017-18	8
Elderly individuals with diabetes and foot ulcer have a probability for healing despite extensive comorbidity and dependency	8
An update on the economic burden of type 2 diabetes mellitus in China	8
Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population	8
Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system	7
A review of quality-of-life in elderly osteoarthritis	7
Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study	7
Not cost-effective at zero price: valuing and paying for combination therapies in cancer	7
Trends in the pricing and reimbursement of new anticancer drugs in South Korea: an analysis of listed anticancer drugs during the past three years	7
Barriers and facilitators of exploiting the potential of value-added medicines	7
Understanding long-listed pharmaceutical products without competition in South Korea: policy implications in managing generic entrants and pharmaceutical expenditures	7
Cost of illness in multiple sclerosis by disease characteristics – A review of reviews	7
Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications	7
Cannabis use among Canadian adults with cancer (2007–2016): results from a national survey	7
Evidence of long-term real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic	7
Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience	7
Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia	7
The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematology	6
Disease burden on health care by pain severity and usual analgesic treatment in patients with symptomatic osteoarthritis: a Spanish nationwide health survey	6
Cost-effectiveness analyses of targeted therapy and immunotherapy for advanced non-small cell lung cancer in the United States: a systematic review	6
Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan	6
Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by BRCA1/2 mutation status for platinum-sensitive relapsed ovarian cancer	6
The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology	6
Pembrolizumab plus lenvatinib or axitinib compared to nivolumab plus ipilimumab or cabozantinib in advanced renal cell carcinoma: a number needed to treat analysis	6
Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment	6
Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer	6
Cost-effectiveness analyses comparing cemented, cementless, hybrid and reverse hybrid fixation in total hip arthroplasty: a systematic overview and critical appraisal of the current evidence	6
The current state of patient access to new drugs in South Korea under the positive list system: evaluation of the changes since the new review pathways	6
Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Gr	6
Burden of Hodgkin and non-Hodgkin lymphoma in Spain over a 10-year period: productivity losses due to premature mortality	6
Exploring the consistency of the SF-6Dv2 in a breast cancer population	6
Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia	6
Cost-effectiveness analysis of donafenib versus lenvatinib for first-line treatment of unresectable or metastatic hepatocellular carcinoma	6
Cost of patients with hemophilia A treated with standard half-life or extended half-life FVIII in Spain	6
Direct medical costs of breast cancer in Jordan: cost drivers and predictors	5
Durvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis	5

Budget impact analysis of subcutaneous trastuzumab compared to intravenous trastuzumab in Saudi HER2-positive breast cancer patients	5
The costs of treatment resistant depression: evidence from a survey among Italian patients	5
Cost-effectiveness of aripiprazole orally disintegrating tablets in the treatment of schizophrenia in China	5
How can societal culture and values influence health and rehabilitation outcomes?	5
Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews	5
Cardiovascular outcome trials of glucose-lowering therapies	5
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspe	5
Incremental cost-effectiveness analysis of tyrosine kinase inhibitors in advanced non-small cell lung cancer with mutations of the epidermal growth factor receptor in Colombia	5
Pharmacoeconomics of obesity in China: a scoping review	5
The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention	5
Short-term societal economic burden of first-incident type 2 diabetes-related complications – a nationwide cohort study	5
A systematic review and meta-regression of studies eliciting willingness-to-pay per quality-adjusted life year in the general population	5
Cost-utility analysis of ceftazidime-avibactam versus colistin-meropenem in the treatment of infections due to Carbapenem-resistant Klebsiella pneumoniae in Colombia	5
A review of caregiver costs included in cost-of-illness studies	4
Letter to the editor on ‘cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomes’	4
A pre-vaccine analysis using the Health Belief Model to explain parents’ willingness to vaccinate (WTV) their children in the United States: implications for vaccination programs	4
Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies	4
In-hospital economic burden of anastomotic leakage after colorectal anastomosis surgery: a real-world cost analysis in Italy	4
The value of communicating with patients in their first language	4
Value elements and methods of value-based pricing for drugs in Japan: a systematic review	4
Cost-related nonadherence for prescription medications: a cross-sectional study in Jordan	4
Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain	4
Bringing the patient’s perspectives forward in drug development and health-care evaluation	4
Early technology assessment of using whole genome sequencing in personalized oncology	4
The Economic and societal burden of multiple sclerosis on lebanese society: a cost-of-illness and quality of life study protocol	4
A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.	4
Cost-effectiveness analysis of apixaban compared to other direct oral anticoagulants for prevention of stroke in Austrian atrial fibrillation patients	4
Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment	4
Assessment of women’s treatment preferences for vasomotor symptoms due to menopause	4
Impact of surgical instrumentation on hospital length of stay and cost of total knee arthroplasty	4
The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey	4
Prevalence and direct costs of potentially inappropriate prescriptions in France: a population-based study	4
Assessing the pricing and benefits of oncology products: an update	4
Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States	4
Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting	4
Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience	4
Burden of illness the first year after diagnosed bladder dysfunction among people with spinal cord injury or multiple sclerosis – a Danish register study	4
Patient preferences for elagolix and leuprolide for treating endometriosis-related pain in the United States	3
Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model	3
Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease	3
Moving beyond the stage: how characteristics at diagnosis dictate treatment and treatment-related quality of life year losses for women with early stage invasive breast cancer	3
Design and testing of a health economic Markov model for treatment of anorexia nervosa	3
Budget impact analysis of medicines: estimated values versus real-world evidence and the implications	3
Economic evaluation of ivabradine in treatment of patients with heart failure: a systematic review	3
Cost-utility analysis of stereotactic body radiotherapy plus cetuximab in previously irradiated recurrent squamous cell carcinoma of the head and neck	3
Assessment of the properties of the EQ-5D-5L in patients with type 2 diabetes mellitus: a systematic review and meta-analysis	3
Pharmacist-directed care to optimize medication use: a healthcare imperative in the United States	3
A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury	3
The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices	3
A landscape analysis and discussion of value of gene therapies for sickle cell disease	3
Burden of depression among Canadian adults with cancer; results from a national survey	3
Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France	3
Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colomb	3
Incorporating health inequality impact into economic evaluation in low- and middle-income countries: a systematic review	3
Cost-effectiveness of pharmacist-led care versus usual care in type 2 diabetic Jordanians: a Markov modeling of cardiovascular diseases prevention	3
Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events	3
All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain	3
The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States	3
Patient associations and clinical oncology research: how much does a patient’s voice really matter?	3
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis	3
Barriers to implementing pharmacoeconomics: interview study	3
Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machine learning approach	3
Tenecteplase in managing acute ischemic stroke: a long-term cost–utility analysis in Iran	3
Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2– metastatic breast cancer in the United States	3
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain	3
Evaluation of quality of pharmacoeconomic studies involved in traditional Chinese medicine in China	3
Cost-effectiveness analysis of polycystic ovary syndrome management and the risk of gestational diabetes in pregnant women: a decision-tree model	3
Characterization of health-related quality of life based on the EQ-5D-5L questionnaire in head-and-neck cancer patients undergoing modern radiotherapy	3
Cost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer	3
Summary of the 2020 AHRQ research meeting on ‘advancing methods of implementing and evaluating patient experience improvement using consumer assessment of healthcare providers and systems (CAHPS®) sur	3
A systematic review of cost-effectiveness analyses across the acute kidney injury landscape	3
Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china	3
Economic evaluation of reproductive carrier screening for recessive genetic conditions: a systematic review	3
Burden of disease and costs of infections associated with cardiac implantable electronic devices	3
Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review	3
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain	3
How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021	2
Can artificial intelligence separate the wheat from the chaff in systematic reviews of health economic articles?	2
The challenge of value-based pricing in combination therapy: the case of trastuzumab and pertuzumab in HER2+ metastatic breast cancer	2
Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE study	2

Predicting SF-6Dv2 utility scores for chronic low back pain using the Oswestry Disability Index and Roland-Morris Disability Questionnaire	2
In our war against the opioid epidemic, could ‘weed’ be a winner?	2
Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review	2
Predicting key drivers for health care expenditure growth in the Middle East region: a Grossman-PLS modeling approach	2
Budgetary impact analysis of alteplase - recombinant tissue plasminogen activator (rtPA) - as a thrombolytic treatment for acute ischemic stroke in Colombia	2
Prescription analysis and cost of antidepressant drugs in major depressive disorder outpatients at the tertiary care hospital of Pakistan: a prospective approach	2
A systematic review of economic evaluations of vaccines in Middle East and North Africa countries: is existing evidence good enough to support policy decision-making?	2
Cost-effectiveness of camrelizumab plus chemotherapy versus chemotherapy alone as first-line therapy in advanced or metastatic esophageal squamous cell carcinoma	2
Multicriteria decision analysis in health care decision in oncology: a systematic review	2
Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care	2
Hyperbaric oxygen therapy as an adjunct to the standard wound care for the treatment of diabetic foot ulcers in Indian patients: a cost utility analysis	2
Analysis of patients’ access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece	2
Conducting economic evaluation based on basket clinical trial in the area of precision medicine	2
Mapping the FACT-G to EQ-5D-3L utility index in cancer with the Chinese values set	2
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant	2
Burden of disease of chronic pain in Colombia	2
Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs	2
Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal	2
Assessing smoking cessation services and pharmacotherapy in Namibia: findings and implications for future policy initiatives	2
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain	2
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada	2
Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies	2
Tackling reimbursement challenges to fair access to medicines – introduction to the topic	2
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer	2
Cost-effectiveness of acalabrutinib regimens in treatment-naïve chronic lymphocytic leukemia in the United States	2
Economic evaluation of toripalimab plus chemotherapy compared with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma in China	2
Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare	2
Hospital incidence, mortality and costs of Alzheimer’s disease in Spain: a retrospective multicenter study	2
Estimating cost-effectiveness of screening for colorectal cancer in Vietnam	2
Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review	2
Medicaid best price reforms to enable innovative payment models for cell and gene therapies	2
A systematic review of pharmacoeconomic evaluations on oral diarylquinoline-based treatment for drug-resistant tuberculosis: from high to low burden countries	2
Performance-based risk-sharing agreements in renal care: current experience and future prospects	2
Exploring the status and views of managed entry agreements in Saudi Arabia: mixed-methods approach	2
Burden of illness among intermittent catheter users with non-neurogenic urinary retention in Denmark	2
Is it a chimera? A systematic review of the economic evaluations of CAR-T cell therapy - an update	2
Systematic reviews of machine learning in healthcare: a literature review	2
Measuring valued output in primary care: challenges and reconciliation	2
Canadian French translation and linguistic validation of the health-related quality of life utility measure for pre-school children	2
The affordability of adding a direct-acting oral anticoagulant to the national list of essential medicine for patients with non-valvular atrial fibrillation in Thailand: a budget impact analysis	2
Combining health technology assessment and health technology management to deliver cost-effective prescribing and cost containment – the Irish experience	2
Assessment of the quality and trend of reporting of health economic evaluation research in India	2
Hospital care of endometriosis in Spain: a retrospective multicenter analysis of patient characteristics and costs	2
Estimation of the economic burden of atrial fibrillation-related stroke in Greece	2
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain	2
Association of congestive heart failure with hospital outcomes among renal cancer patients in the United States: analysis of nationwide inpatient sample	2
Incorporating patients’ preferences in the value assessment of disease-modifying therapies for multiple sclerosis: a narrative review	2
Identification of cognitively impaired patients at risk for development of Alzheimer’s disease dementia: an analysis of US Medicare claims data	1
Economic benefits of global Collaborative Health technology	1
Letter to the editor regarding “Budget impact analysis of pneumococcal conjugate vaccines in Colombia”	1
A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer	1
Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review	1
Analysis of the prevalence of ankylosing spondylitis and treatment patterns and drug utilization among affected patients: an Italian real-world study	1
Economic evaluation of plerixafor addition in the mobilization and leukapheresis of hematopoietic stem cells for autologous transplantation: a systematic review	1
Cost considerations of dermatological care in Jordan: a cross-sectional study	1
A systematic review of economic evaluations of treatment regimens in multiple myeloma	1
Review of economic modeling evidence from NICE appraisals of rare disease treatments for spinal muscular atrophy	1
Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis	1
The budget impact of introducing the OMNI® surgical system to a United States health plan for managing mild-to-moderate primary open-angle glaucoma	1
Psychometric properties of the Polish version of SF-12v2 in the general population survey	1
A visual approach to the economic evaluation of vaccines: opening the health economic black box	1
What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?	1
Economic evaluation of interventions to improve medication adherence among patients with chronic diseases: an overview of systematic reviews	1
Cost-utility model of brivaracetam in the adjunctive treatment of patients with epilepsy in Spain	1
The burden of productivity loss of U.S. commercially insured patients diagnosed with Dupuytren’s disease undergoing collagenase versus fasciectomy treatment	1
Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database	1
Accounting for inflation within NICE cost-effectiveness thresholds	1
A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis	1
Capturing the holistic value of biosimilars in Europe – part 1: a historical perspective	1
Effects of utilization management on health outcomes: evidence from urinary tract infections and community-acquired pneumonia	1
Value assessment of new interventions for Alzheimer’s disease dementia in Japan based on literature review and group interview	1
Early economic evaluation of an intervention to improve uptake of the NHS England Diabetes Prevention Programme	1
Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China	1
The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach	1
Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand	1
Value-based health care in Western countries: a scoping review on the implementation of patient-reported-outcomes sets for hospital-based interventions	1
Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil	1
Cost-effectiveness and drug wastage of immunotherapeutic agents for hematologic malignancies: a systematic review	1
Prescribers’ opinions to identify competitive groups: a comparative analysis in the pharmaceutical industry	1
Clinical and economic outcomes associated with intravenous albumin fluid use in the intensive care unit: a retrospective cohort study	1
Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder	1
Direct medical and indirect absenteeism costs among working adult ADHD patients in the United States	1
Cost-effectiveness of nivolumab in advanced melanoma: a drug review	1
Kick-off meeting of the TOWWERS showcase project: 1st collaborative value-based healthcare anchored on real-world data involving the 5P+	1
Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study	1
Evaluation of the Cost-Utility of the York Faecal Calprotectin Care Pathway	1
Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment	1
Predictive modeling to identify potential participants of a disease management program hypertension	1
Health equity and the usage of atypical antipsychotics within the Brazilian national health system: findings and implications	1
Measuring health-related quality of life in patients treated for substance dependence: differences among instruments and methods of eliciting preferences	1
Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?	1
The cost-effectiveness of using rapid diagnostic tests for the diagnosis of typhoid fever in patients with suspected typhoid fever: a systematic review	1
Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reforms	1
Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological ana	1
Evaluating the correlations of cost and utility parameters from summary statistics for probabilistic analysis in economic evaluations	1